Drug Resistance Lower Than Previously Thought Among People On PrEP, Study Shows

Center for Global Health Policy’s “Science Speaks”: PrEP: Risk of resistance to antiretroviral drugs used to prevent infection is lower than thought, study finds
Antigone Barton, writer and editor of “Science Speaks” and senior communications officer at the Center for Global Health Policy, discusses a study published in the January 13 issue of the Journal of Infectious Diseases showing that pre-exposure prophylaxis “poses lower risks of later resistance to the drugs than previously thought” (1/14).